Skip to main content

Table 2 The risk model of immune lncRNA expression

From: Construction of immune-related lncRNA signature to predict aggressiveness, immune landscape, and drug resistance of colon cancer

ID

coef

HR

HR.95L

HR.95H

p value

AP001469.3

0.574505872

1.776252615

0.998051245

3.161233822

0.050780302

AP001453.2

 − 0.363495071

0.695242154

0.432289518

1.118143358

0.133783345

AC007128.1

0.427241742

1.533023213

0.924508885

2.542063371

0.097768947

AC124067.4

 − 0.269272158

0.763935316

0.611645819

0.954142331

0.017606639

LINC00513

 − 0.419186774

0.657581365

0.470812319

0.918440818

0.013930483

FENDRR

 − 0.310222378

0.733283872

0.517954308

1.038132571

0.080294969

AL137782.1

 − 0.74476217

0.474847219

0.231960611

0.972061078

0.041601358

NKILA

0.514359624

1.672567087

1.217886075

2.296997001

0.001484107

AL590483.1

 − 0.773741406

0.461283985

0.268857903

0.79143262

0.004966124

AC010973.2

1.34334251

3.831830054

2.112475134

6.950577227

9.80E−06

AL354993.2

0.422350358

1.525542918

0.972653578

2.392713343

0.065882942